Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Tildrakizumab: monoclonal antibody against IL-23p19 for moderate to severe psoriasis.

Paton DM.

Drugs Today (Barc). 2018 Jul;54(7):433-444. doi: 10.1358/dot.2018.54.7.2866117.

PMID:
30090880
2.

Guselkumab: human monoclonal antibody against interleukin-23 for moderate to severe psoriasis.

Paton DM.

Drugs Today (Barc). 2018 Mar;54(3):199-207. doi: 10.1358/dot.2018.54.3.2795155. Review.

PMID:
29771254
3.

Dupilumab: human monoclonal antibody against IL-4Rα for moderate to severe atopic dermatitis.

Paton DM.

Drugs Today (Barc). 2017 Sep;53(9):477-487. doi: 10.1358/dot.2017.53.9.2693150.

PMID:
29238761
4.

Nusinersen: antisense oligonucleotide to increase SMN protein production in spinal muscular atrophy.

Paton DM.

Drugs Today (Barc). 2017 Jun;53(6):327-337. doi: 10.1358/dot.2017.53.6.2652413. Review.

PMID:
28799578
5.

Crisaborole: Phosphodiesterase inhibitor for treatment of atopic dermatitis.

Paton DM.

Drugs Today (Barc). 2017 Apr;53(4):239-245. doi: 10.1358/dot.2017.53.4.2604174. Review.

PMID:
28492291
6.

Deutetrabenazine: Treatment of hyperkinetic aspects of Huntington's disease, tardive dyskinesia and Tourette syndrome.

Paton DM.

Drugs Today (Barc). 2017 Feb;53(2):89-102. doi: 10.1358/dot.2017.53.2.2589164. Review.

PMID:
28387387
7.

Nebivolol/valsartan: Fixed-dose combination for treatment of hypertension.

Paton DM.

Drugs Today (Barc). 2017 Jan;53(1):19-26. doi: 10.1358/dot.2017.53.1.2560078. Review.

PMID:
28387384
8.

Clinical Trials Involving Hypertension.

Paton DM.

N Engl J Med. 2017 Jan 19;376(3):289. No abstract available.

PMID:
28102650
9.

Lifitegrast: First LFA-1/ICAM-1 antagonist for treatment of dry eye disease.

Paton DM.

Drugs Today (Barc). 2016 Sep;52(9):485-493.

PMID:
27883115
10.

Reslizumab: Maintenance treatment for eosinophilic asthma inadequately controlled on corticosteroids.

Paton DM.

Drugs Today (Barc). 2016 Jun;52(6):323-9. doi: 10.1358/dot.2016.52.6.2510261. Review.

PMID:
27458609
11.

Letter by Paton Regarding Article, "Knowing the Prevalence of Familial Hypercholesterolemia Matters".

Paton DM.

Circulation. 2016 Jul 19;134(3):e17-8. doi: 10.1161/CIRCULATIONAHA.116.022606. No abstract available.

PMID:
27436887
12.

Sebelipase alfa: enzymatic replacement treatment for lysosomal acid lipase deficiency.

Paton DM.

Drugs Today (Barc). 2016 May;52(5):287-93. doi: 10.1358/dot.2016.52.5.2488974. Review.

PMID:
27376161
13.

PCSK9 inhibitors: monoclonal antibodies for the treatment of hypercholesterolemia.

Paton DM.

Drugs Today (Barc). 2016 Mar;52(3):183-92. doi: 10.1358/dot.2016.52.3.2440527. Review.

PMID:
27186592
14.

Patiromer: a significant advance in the management of hyperkalemia.

Paton DM.

Drugs Today (Barc). 2015 Dec;51(12):695-703. doi: 10.1358/dot.2015.51.12.2420391. Review.

PMID:
26798850
15.

Liraglutide in Weight Management.

Paton DM.

N Engl J Med. 2015 Oct 29;373(18):1781. doi: 10.1056/NEJMc1509759. No abstract available.

PMID:
26510033
16.

Ospemifene for the treatment of dyspareunia in postmenopausal women.

Paton DM.

Drugs Today (Barc). 2014 May;50(5):357-64. doi: 10.1358/dot.2014.50.5.2134451. Review.

PMID:
24918836
17.
18.

Euglobal-In-1, a new euglobal from Eucalyptus incrassata.

Takasaki M, Konoshima T, Kozuka M, Haruna M, Ito K, Crow WD, Paton DM.

Chem Pharm Bull (Tokyo). 1994 Oct;42(10):2113-6.

PMID:
7805137
19.
20.

Ethical aspects of a study of the effects of aspirin on the healing of duodenal ulcer.

Paton DM.

Aust N Z J Med. 1991 Feb;21(1):80-1. No abstract available.

PMID:
2036084
21.
22.

A comparison of P1- and P2-purinoceptors.

Paton DM, Taerum T.

Ann N Y Acad Sci. 1990;603:165-71. Review. No abstract available.

PMID:
2291518
23.
24.

New cardiotonics may act via adenosine receptors. Mechanisms of action of the new cardiotonic drugs.

Paton DM, Manuel JM.

Trends Pharmacol Sci. 1988 Dec;9(12):431-2. No abstract available.

PMID:
3270961
25.

Clinical use of triazolam.

Paton DM.

J Can Dent Assoc. 1988 Dec;54(12):883. No abstract available.

PMID:
3063357
26.

Actions of amrinone and milrinone on the guinea-pig ileum.

Stone TW, Paton DM.

J Pharm Pharmacol. 1988 Jul;40(7):521-3.

PMID:
2904999
27.

Comparative bioavailability of two tablet preparations of metronidazole.

Paton DM, Webster DR.

Int J Clin Pharmacol Res. 1988;8(4):227-9.

PMID:
3182111
28.

Potency of N6-modified N-alkyl adenosine-5'-uronamides at presynaptic adenosine receptors in guinea-pig ileum.

Paton DM, Lockwood PA, Martlew DL, Olsson RA.

Naunyn Schmiedebergs Arch Pharmacol. 1987 Mar;335(3):301-4.

PMID:
3587372
29.
30.

Nature of the N6 region of the adenosine receptor in guinea-pig ileum and rat vas deferens.

Paton DM, Olsson RA, Thompson RT.

Naunyn Schmiedebergs Arch Pharmacol. 1986 Jul;333(3):313-22.

PMID:
2945115
31.

Relationship of metabolism of 2'-, 3'- and 5'-adenine nucleotides to presynaptic inhibition of transmitter release in rat vas deferens.

Webster DR, Boston GD, Holford NH, Paton DM.

Naunyn Schmiedebergs Arch Pharmacol. 1986 Jun;333(2):163-7.

PMID:
2875398
32.

Comparative bioavailability and half-lives of cloxacillin and flucloxacillin.

Paton DM.

Int J Clin Pharmacol Res. 1986;6(5):347-9.

PMID:
3781696
33.

Mechanism of urate production by guinea-pig ileum.

Webster DR, Boston GD, Paton DM.

Adv Exp Med Biol. 1986;195 Pt B:239-43. No abstract available.

PMID:
3490124
34.

Purine metabolism by guinea-pig ileum.

Webster DR, Boston G, Paton DM.

Adv Exp Med Biol. 1986;195 Pt B:19-28. No abstract available.

PMID:
3490118
35.

Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines).

Paton DM, Webster DR.

Clin Pharmacokinet. 1985 Nov-Dec;10(6):477-97. Review.

PMID:
2866055
36.

Measurement of adenosine metabolites and metabolism in isolated tissue preparations.

Webster DR, Boston GD, Paton DM.

J Pharmacol Methods. 1985 Jul;13(4):339-50.

PMID:
4021500
37.

Mechanism of presynaptic inhibition of cholinergic transmission in guinea-pig ileum by adenine nucleotides.

Paton DM, Broome SG, Webster DR.

Methods Find Exp Clin Pharmacol. 1985 Feb;7(2):65-8.

PMID:
2985893
38.
39.

Adverse drug reactions in the elderly.

Paton DM.

S Afr Med J. 1984 Jul 21;66(3):84. No abstract available.

PMID:
6740437
40.

Classification of adenosine receptors.

Paton DM.

Methods Find Exp Clin Pharmacol. 1984 Apr;6(4):167-9. No abstract available.

PMID:
6087047
41.

A review of the clinical pharmacokinetics of amiodarone.

Paton DM, Webster DR, Neutze JM.

Methods Find Exp Clin Pharmacol. 1984 Jan;6(1):41-9. Review. No abstract available.

PMID:
6371407
42.

Therapy of chancroid with trimethoprim-sulfametrole.

Webster DR, Paton DM.

N Engl J Med. 1983 Dec 29;309(26):1652. No abstract available.

PMID:
6646193
43.

No impairment of antipyrine elimination by the selective anticholinergic drug pirenzepine.

Paxton JW, Foote SE, Paton DM.

Digestion. 1983;27(1):44-6.

PMID:
6688400
44.

Bioavailability and half-life of two preparations of flucloxacillin.

Paton DM, Mander P, Avery RJ.

N Z Med J. 1982 Nov 10;95(719):766-8.

PMID:
6959033
45.

Effects of G, a Growth Regulator from Eucalyptus grandis, on Photosynthesis.

Sharkey TD, Stevenson GF, Paton DM.

Plant Physiol. 1982 Apr;69(4):935-8.

46.

Metabolism and presynaptic inhibitory activity of 2',3' and 5'-adenine nucleotides in rat vas deferens.

Willemot J, Paton DM.

Naunyn Schmiedebergs Arch Pharmacol. 1981 Sep;317(2):110-4.

PMID:
7300914
48.

Metabolism and presynaptic inhibitory effects of adenosine in rat vas deferens.

Willemot J, Paton DM.

J Auton Pharmacol. 1981 Jun;1(3):217-24.

PMID:
7338527
50.

Effect of eucalyptus growth regulators on the water loss from plant leaves.

Paton DM, Dhawan AK, Willing RR.

Plant Physiol. 1980 Aug;66(2):254-6.

Supplemental Content

Loading ...
Support Center